BRAF inhibitors: resistance and the promise of combination treatments for melanoma. (2017)

First Author: Griffin M
Attributed to:  Clinical Translation of Gene Modified T-cell Therapy for Solid Tumours funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.18632/oncotarget.19836

PubMed Identifier: 29100459

Publication URI: http://europepmc.org/abstract/MED/29100459

Type: Journal Article/Review

Volume: 8

Parent Publication: Oncotarget

Issue: 44

ISSN: 1949-2553